Cingulate Stock Market Value
| CING Stock | USD 3.70 0.10 2.63% |
| Symbol | Cingulate |
Cingulate Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cingulate. If investors know Cingulate will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cingulate listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Cingulate is measured differently than its book value, which is the value of Cingulate that is recorded on the company's balance sheet. Investors also form their own opinion of Cingulate's value that differs from its market value or its book value, called intrinsic value, which is Cingulate's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cingulate's market value can be influenced by many factors that don't directly affect Cingulate's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cingulate's value and its price as these two are different measures arrived at by different means. Investors typically determine if Cingulate is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cingulate's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cingulate 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Cingulate's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Cingulate.
| 08/07/2025 |
| 11/05/2025 |
If you would invest 0.00 in Cingulate on August 7, 2025 and sell it all today you would earn a total of 0.00 from holding Cingulate or generate 0.0% return on investment in Cingulate over 90 days. Cingulate is related to or competes with Allarity Therapeutics, Rallybio Corp, Lunai Bioworks, Clearside Biomedical, Lisata Therapeutics, SAB Biotherapeutics, and NanoViricides. Cingulate Inc., a clinical-stage biopharmaceutical company, focuses on the development of product candidates for the tre... More
Cingulate Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Cingulate's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Cingulate upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.14) | |||
| Maximum Drawdown | 21.84 | |||
| Value At Risk | (6.86) | |||
| Potential Upside | 6.89 |
Cingulate Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Cingulate's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Cingulate's standard deviation. In reality, there are many statistical measures that can use Cingulate historical prices to predict the future Cingulate's volatility.| Risk Adjusted Performance | (0.06) | |||
| Jensen Alpha | (0.65) | |||
| Total Risk Alpha | (1.21) | |||
| Treynor Ratio | (0.40) |
Cingulate Backtested Returns
Cingulate secures Sharpe Ratio (or Efficiency) of -0.0298, which signifies that the company had a -0.0298 % return per unit of risk over the last 3 months. Cingulate exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Cingulate's Mean Deviation of 3.47, risk adjusted performance of (0.06), and Standard Deviation of 4.57 to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 1.34, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Cingulate will likely underperform. At this point, Cingulate has a negative expected return of -0.12%. Please make sure to confirm Cingulate's value at risk, as well as the relationship between the accumulation distribution and day typical price , to decide if Cingulate performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.46 |
Average predictability
Cingulate has average predictability. Overlapping area represents the amount of predictability between Cingulate time series from 7th of August 2025 to 21st of September 2025 and 21st of September 2025 to 5th of November 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Cingulate price movement. The serial correlation of 0.46 indicates that about 46.0% of current Cingulate price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.46 | |
| Spearman Rank Test | -0.01 | |
| Residual Average | 0.0 | |
| Price Variance | 0.04 |
Cingulate lagged returns against current returns
Autocorrelation, which is Cingulate stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Cingulate's stock expected returns. We can calculate the autocorrelation of Cingulate returns to help us make a trade decision. For example, suppose you find that Cingulate has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Cingulate regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Cingulate stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Cingulate stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Cingulate stock over time.
Current vs Lagged Prices |
| Timeline |
Cingulate Lagged Returns
When evaluating Cingulate's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Cingulate stock have on its future price. Cingulate autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Cingulate autocorrelation shows the relationship between Cingulate stock current value and its past values and can show if there is a momentum factor associated with investing in Cingulate.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
| VOO | Vanguard SP 500 | |
| XLK | Technology Select Sector | |
| XLV | Health Care Select | |
| QQQ | Invesco QQQ Trust | |
| XLC | Communication Services Select |
Check out Cingulate Correlation, Cingulate Volatility and Cingulate Alpha and Beta module to complement your research on Cingulate. For more detail on how to invest in Cingulate Stock please use our How to Invest in Cingulate guide.You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Cingulate technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.